Introduction
Approximately 10% to 40% of general populations report chronic or recurrent dyspeptic symptoms such as epigastric pain and discomfort. 1, 2 It is estimated that approximately one out of two people seeks health care for their dyspepsia at some time in their life. 1, 3 Functional dyspepsia (FD) is defined as the presence of one or more dyspepsia symptoms that are considered to originate from the gastroduodenal regions, in the absence of any organic, systematic, or metabolic disease that is likely to be responsible for the symptoms. 4 About 45% to 65% of the patients suffering from chronic or recurrent dyspeptic symptoms have been diagnosed as FD 5, 6 and FD is one of the commonest diseases in the field of Internal Medicine.
In terms of terminology related to FD, one of the crucial problems underlying FD care in medical facilities under the regulation of Japanese medical insurance system had been an absence of suitable and acceptable translation of "dyspepsia" into Japanese. The Japanese Society of Gastroenterology (JSGE) has been enlightening the term and concept of FD for last several years in accordance with the worldwide spread of enlightenment on functional gastrointestinal disorders (FGID) by Rome committee (Rome criteria). 7 The JSGE has recommended the diagnostic term as "functional dyspepsia" by the combination of Japanese Kanji characters and Katakana letters, although almost all the diagnostic terms in Japanese have been expressed by Kanji. In Japan, acotiamide 8 has been just launched in June, 2013 for FD described by Kanji and Katakana letters for the first time.
Physicians did not record FD as a diagnosis in the medical record before the release of acotiamide, although much knowledge of FD has been present. However, understanding the medical terms related to FD has not been reported. From another viewpoint, it has been pointed out that dyspepsia is not a term usually understood by patients. 9 In terms of drug therapy for FD, acid-suppressive and prokinetic drugs have been effective for dyspepsia, 10 although high-quality studies investigating the true utility of these agents applicable for FD in a randomized and blinded fashion are still lacking. 11 As it has been reported that the quality of life of FD patients is impaired, 7, 12 and that employees with FD have greater costs at all places of service and lower productivity than employees without FD, 13 
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Participants
This study was conducted on attendees at lifelong education courses for certified members of the Japanese Society of Internal Medicine (JSIM). The educational programs were held in 3 cities (Tokyo, Osaka and Sendai) of Japan in 2009, and 4,264 physicians attended. Data were obtained from self-administered questionnaires concerning persistent dyspeptic symptom(s) located in the epigastrium without definite or possible organic disease (functional dyspepsia like [FD-L]). The questionnaires were distributed to the attendances prior to the lectures, and 1,660 attendees aged 24 to 90 years old (38.9%) agreed to participate in the present study. This protocol was approved by the JSIM. A submission was optional and unregistered, and it did not affect the credit of the education course. This ethical information was written clearly in the instruction of the questionnaire.
Measures
The questionnaire contains demographic information including age (10-year interval), gender, specialty (Internal Medicine, Surgery, Psychiatry and Pediatrics etc.), specific field (Gastroenterology/other fields of Medicine: Cardiology, Endocrinology, Hematology and Neurology etc/General Medicine), periods of clinical experience (less or equal to 5 years/ 6 to 10 years/11 to 20 years/21 to 30 years/31 to 40 years/more than 40 years), working form (practitioner/hospital doctor/others), working area judged by submitter (urban/suburban/rural), certified doctor by JSIM (yes/no) and certified specialist by the JSGE (yes/no). It was also assessed: understandings of the medical terms listed below (more than one was permitted), monthly care number of FD-L patients, the way to inform the FD-L symptoms to patients, medication, attitudes towards the FD-L patients, and knowledge and application of the Rome criteria.
Medical terms considered included FD in English, FD by Japanese Kanji, FD by Kanji and Katakana and non-ulcer dyspepsia (NUD) in English; other medical terms listed in Kanji characters which have been officially and clinically utilized in gastrointestinal tract diseases were irritable bowel syndrome (IBS), chronic gastritis, reflux esophagitis and non-erosive reflux disease (NERD).
Statistical Methods
Data were analyzed using the IBM SPSS Statistics software (Japanese version 19; IBM SPSS, Tokyo, Japan). Chi-square test was utilized for comparison of knowledge on medical terminology according by each factors. Binary logistic regression model was applied to calculate odds ratios (OR) and 95% confidence intervals (CI) for assessing variables related with the knowledge of medical terms expressing FD-L, related variables with physicians' attitude towards caring for FD-L patients, and related variables with knowledge and application of the Rome criteria. A probability P-value less than 0.05 was considered significant.
Results
Nineteen participants with missing values concerning FD-L questions, 8 who were working outside of the Internal Medicine, and 10 whose working fields were uncertain were excluded prior to analysis; consequently, 1,623 subjects were analyzed. Table 1 presents characteristics of analyzed participants. Almost all of the responders (96.0%) were the certified doctor by the JSIM. Participants (n = 1,623) knew the term "reflux esophagitis" the most (97.5%), followed by "IBS" (95.6%), "chronic gastritis" (95.5%), FD (68.9%), "FD by Japanese Kanji" (66.9%), "FD by Japanese Kanji and Katakana" (62.0%), NUD (61.6%), and "NERD" (58.7%) ( Table 1) .
Difference in knowledge of each medical term from the viewpoint of variables was analyzed by chi-square tests (data not shown). FD, "FD by Kanji," "FD by Kanji and Katakana," "NUD" and "NERD" were significantly highly recognized among physicians with specific field of Gastroenterology, certified specialist by the JSGE, working as a practitioner, and caring for many patients. FD, "FD by Kanji and Katakana," and NUD, but not "FD by Kanji," were more recognized in doctors with clinical experience duration of 11 to 40 years compared to those of either less than 11 or more than 40 years. "Chronic gastritis," FD, functional dyspepsia; NUD, non-ulcer dyspepsia; FD-L, functional dyspepsia-like (means persistent dyspeptic symptoms located in the epigastrium without organic diseases). "IBS" and "reflux esophagitis" were highly known in regardless of period of clinical experience, working form and number of caring FD-L patients per month.
Next, logistic regression analysis was applied to find out variables that can be related with the understanding of terms expressing FD-L. Table 2 reveals OR and 95% CI of independent variables to explain each term of FD-L. The internists who had been caring more number of FD-L patients per month significantly understood more all of the 4 terms (FD, "FD by Kanji," "FD by Kanji and Katakana" and NUD) in comparison with those who did not. Subjects who were engaged in gastroenterology, and certified internists by the JSGE knew all 4 terms concerning FD more significantly in comparison with the references. Internists with 11-40 years of clinical experiences knew FD and "FD by kanji and katakana" significantly more in comparison with those with more than 41 years of clinical experiences, and internists with less than 40 years of clinical experiences knew NUD more in comparison with those with more than 41 years of clinical experiences, whereas there were no significant differences in "FD by kanji" according to period of clinical experiences.
Out of 1,623 doctors, 1,372 had been caring for FD-L patients (84.5%). Among the 1,372 physicians, 697 (50.8%) used "FD by Japanese Kanji" for informing FD-L patients, and 686 (50.0%) utilized "chronic gastritis" ( Table 3 ). Explanation of "FD by Japanese Kanji and Katakana" and "no worry" was 18.6% and 12.0%, respectively. Prokinetic agent (79.4%) and gastric acid secretion inhibitor (66.3%) were frequently prescribed. Anxiolytics (25.1%) and antidepressants (12.2%) were also used (Table 3 ). In terms of the care attitude, 72.6% of physicians generally cared for the FD-L patients in daily practice. And 23.6% enthusiastically (intensively) took care of the patients. In reference to the Rome criteria, 547 out of 1,372 physicians with caring FD-L patients (39.9%) knew the criteria, and 174 out of 547 (31.8%) applied it to patient care ( Table 3) .
Variables affecting physicians' attitudes in caring for FD-L patients were also analyzed. Table 4 displays OR and 95% CI analyzed by multiple logistic regression: examining FD-L patients enthusiastically (n = 296) vs. others (n = 1,075: including generally and unwillingly; Table 3 ). Female internists in comparison with male, certified internists by the JSIM in comparison with uncertified, period of clinical experience longer than 31 years in comparison with less than 10 years, and hospital doctors in comparison with practitioners cared for FD-L patients less enthusiastically significantly. On the other hand, certified physicians by the JSGE in comparison with uncertified, and physicians who cared more than 6 FD-L patients per month in comparison with those less than 5 per month cared for FD-L patients more enthusiastically. One value is missing, and total of 1,371 were analyzed, b Including research, industrial medicine, nursing home and part-time etc. FD-L, functional dyspepsia-like (means persistent dyspeptic symptoms located in the epigastrium without organic diseases). We analyzed 1,372 participants who cared for FD-L patients out of 1,623 (see Table 1 ).
Only 277 out of the 709 practitioners (39%) knew the Rome criteria, compared to 155 out of 187 hospital specialists (e.g., internists with Gastroenterology subspecialty working at hospital) (83%) (Chi-square = 114, P ＜ 0.00001), and 306 out of 408 certified physicians by the JSGE (75%) (Chi-square = 134, P ＜ 0.00001). The positive factor for the awareness was certified physicians by the JSGE and the more number of caring FD-L patients per month ( Table 5 ). The negative factor for the application was periods of clinical experience of "21-30" and "more than 40" years in comparison with the experience with "less or equal to 10 years." The working form did not affect the knowledge of Rome criteria (Table 5 ).
In 547 participants who understood the Rome criteria, factors that affect application of the criteria to clinical practice were analyzed by a logistic regression model: ORs and 95% CIs of each variable associated with the application of the Rome criteria are exhibited in Table 6 . The positive factor for the application was the more number of caring FD-L patients per month. The negative factor for the application was periods of clinical experience with "11-20," "21-30" and "31-40" years in comparison with the experience with "less or equal to 10 years." The working form and JSGE certified physician did not affect the utilization of Rome criteria. FD-L, functional dyspepsia-like (means persistent dyspeptic symptoms located in the epigastrium without organic diseases). As 2 data are missing in "Knowledge of Rome criteria," remained 1,621 were analyzed. Selected independent variables except for working form were significantly related with knowledge of Rome criteria by univariate regression analysis.
Discussion
Physicians have been labeling "chronic gastritis" in patients with gastric mucosal inflammation that is confirmed by histological or endoscopic findings and/or persistent dyspeptic symptom(s) in the absence of organic diseases such as peptic ulcer. In practice, a diagnosis of chronic gastritis in Japan is primarily based on upper abdominal symptoms without performing an endoscopic examination especially among primary care physicians. 16 Additionally, FD had not been listed under Japanese medical insurance system until June, 2013. In fact, prokinetic drugs including mosapride and itopride have been prescribed with an indication of chronic gastritis-related dyspeptic symptom(s) in Japan. Therefore, it seemed reasonable that the percentage of knowing FD and FD-related terms was lower than that of chronic gastritis in the present study. As this study was performed in 2009, the present recognition rate of FD might be higher due to the recent launch of acotiamide for FD, 8 but not for chronic gastritis, for the first time in 2013. However, knowledge of NERD was 58.7%, which was lower than that of FD, although a certain proton pump inhibitor, which has been prescribed in patients with peptic ulcer and reflux esophagitis, was already approved as additional application for NERD in 2006. Therefore, it is unlikely that the relatively low percentage of recognition of the term FD demonstrated in the present study solely depended on the lack of FD as medically permitted record and on the 3-year interval of the research. The present findings that chronic gastritis, IBS and reflux esophagitis were highly known in regardless of working form and number of caring FD-L patients per month, and that FD, FD by Kanji, FD by Kanji and Katakana, NUD and NERD were significantly highly recognized among physicians working as a practitioner, and caring many patients suggest that FD and FD-related terms were well recognized among practitioners caring for more FD-L patients. This was proved by the analysis of the present study (data not shown). The logistic regression analysis revealed that recognition of FD by Kanji did not differ in terms of period of clinical experience and working form in contrast to that of FD by Kanji and Katakana ( Table 2 ). The discrepancy may re- FD-L, functional dyspepsia-like (means persistent dyspeptic symptoms located in the epigastrium without organic diseases). The number of analyzed participants was 547, which was selected from 1,372 physicians caring for FD-L patients regularly (see Table 3 ). As to 23 data are missing in "Application of Rome criteria into clinical care" remained 524 were analyzed. Selected independent variables except for working form were significantly related with application of Rome criteria into clinical care by univariate regression analysis.
flect the exceptional usage of Katakana as terms of medical record in Japan.
In terms of explanation to FD-L patients from internists, approximately a half of them used the term FD by Japanese Kanji (50.8%) and/or chronic gastritis (50.5%), whereas 18.6% of the doctors explained patients' disorder as FD by Kanji strated that among FD-L patients without any specific lesions detected by endoscopy (n = 937), gastrointestinal symptoms were resolved within one week after the endoscopy in 264 (28.2%) patients before initiating medication with either mosapride or teprenone, the gastroprotective drugs in Japan. Taken together, detailed explanation of "no visible malignant or progressive abnormality by endoscopy" in addition to "no worry" informed by physicians may be warranted at the initial stage of caring for FD patients. The present survey revealed that prokinetic agents and/or gastric acid secretion inhibitors were frequently prescribed at a percentage of 79.4% and 66.3%, respectively. These results are in the line of recommendation of Rome committee.
10 Anxiolytics (25.1%) and/or antidepressants (12.2%) were also prescribed in the present study. These classes of drugs have been demonstrated to be effective for FD. 20 Of note, positive factors for intensive or enthusiastic care for FD-L patients were certified physicians by the JSGE, practitioner, and more number of caring FD-L in the present study. Dalton et al 21 demonstrated that doctors perceived that patients with organic diagnoses had more serious problems, greater disability, and more reasonable requests (P ＜ 0.05 to P ＜ 0.001), compared to those with functional. On the contrary, the patients with functional disorders believed they were more disabled than those with organic disorders (P ＜ 0.05). The doctors should recognize this discrepancy of recognition toward FGID.
In terms of the recognition of Rome criteria, approximately 40% of internists knew the Rome criteria. Gladman and Gorard 22 investigated awareness and utilization of Rome criteria for the diagnosis of FGID among 137 GPs and 167 British Society of Gastroenterology members (consultants). Only 16 of 137 GPs (12%) had heard the Rome criteria, compared to 139 of 167 consultants (83%) (P ＜ 0.0001). Despite the greater awareness among consultants, 67 consultants (40%) reported to use the Rome criteria. Only 4 (3%) of GPs stated that they used it. 22 They used the knowledge and utilization of Rome criteria mainly for IBS. Therefore, present study is the first research on awareness of internists of Rome criteria for FD. In the present study, hospital specialists and certified physicians by the JSGE knew more about the Rome criteria compared to practitioners, in agreement with the report by Gladman and Gorard. 22 However, working form did not affect the knowledge of Rome criteria by multiple logistic regression analysis. Our data suggested that number of caring FD-L patients was crucial in the knowledge of Rome criteria whether the physician was certified or not by the JSGE. Among the present subjects with knowledge of the Rome criteria (n = 547), 174 (31.8%) applied the Rome criteria for FD-L patients' care. Of note, the JSGE certified physician was not a factor to affect the utilization of Rome criteria. The reason of the present discrepancy between awareness and application of the Rome criteria among certified physicians by JSGE remains unknown. The criterion for the time from the symptom onset as defined by the Rome III might be responsible, because the patients with dyspepsia usually visit the hospital for evaluation sooner than the 6 months, which is defined as minimum symptom onset time prior to FD diagnosis in the Rome III, in Japan. 16, 23 There were no significant differences in severity of dyspeptic symptoms between the 3 groups (less than 1 month, from 1 to 6 months and more than 6 months). 16, 23 Therefore, Manabe et al 23 concluded that the 6-month period after onset of dyspeptic symptoms should be shortened at least in the Japanese population experiencing dyspeptic symptoms. The limitations of the present study include that it is unknown whether the present findings concerning the awareness of terms related to FD and Rome criteria and the attitude toward FD-L patients represent Japanese internists. The subjects were attendees at lifelong education courses for mainly certified member of JSIM, but not recruited randomly from Japanese internists. The percentage of the specific field as Gastroenterology in the present study (25.1%) was higher than that of the national survey (17.8%) released from the Ministry of Health, Labor and Welfare in 2010 (http://www.mhlw.go.jp/toukei/saikin/hw/ishi/10/ dl/gaikyo.pdf in Japanese). In addition, although criteria of Rome definition have been changed from I through III, 24 it cannot be determined as to which version of them was relatively known and utilized under the present setting. The present results are limited to one nation, as available data outside of Japan are lacking.
In conclusion, the results that awareness rate of the terms related to FD was low compared with that of chronic gastritis, whereas the explanation from internists to FD-L patients was FD and chronic gastritis at a similar rate (50.8% and 50.0%, respectively) suggest a certain portion of Japanese internists utilized the functional disorder to inform the patients with FD-L. Low rate of explanation term as FD by Japanese Kanji and Katakana and utilization of Rome criteria especially among specialists of Gastroenterology might indicate needs of enlightening the medical term in Japan and revision of Rome criteria for routine clinical practice. Publication of the clinical guideline for FD from the JSGE is scheduled in 2014 and the release of new drug for FD in 2013 may be expected to improve the FD care including terminology with higher motivation to treat FD patients and the position of Rome criteria.
